EZZ Life Science Holdings Ltd (EZZ) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.02x

EZZ Life Science Holdings Ltd (EZZ) has a Cash Flow Reinvestment Rate of 0.02x as of June 2025, reinvesting AU$48.35K (capex AU$48.35K ) from operating cash flow of AU$2.86 Million. See free cash flow generation of EZZ Life Science Holdings Ltd to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.02x
(Capex + Investments) / Operating CF

Total Reinvested

AU$48.35K
Capex + Investments

Operating Cash Flow

AU$2.86 Million
AUD

Capital Expenditures

AU$48.35K
AUD

EZZ Life Science Holdings Ltd Cash Flow Reinvestment Rate (2018–2024)

Historical reinvestment intensity for EZZ Life Science Holdings Ltd across 7 annual periods. For the full cash flow conversion analysis, see EZZ Life Science Holdings Ltd (EZZ) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for EZZ Life Science Holdings Ltd (2018–2024)

Year-by-year capital reinvestment analysis for EZZ Life Science Holdings Ltd. See financial agility of EZZ Life Science Holdings Ltd to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2024 0.19x AU$807.81K AU$4.35 Million AU$260.88K ▲ +34.1%
2023 0.14x AU$850.46K AU$6.14 Million AU$409.29K ▲ +173.0%
2022 0.05x AU$203.57K AU$4.01 Million AU$101.78K ▲ +266.0%
2021 0.01x AU$26.35K AU$1.90 Million AU$13.18K ▼ -89.1%
2020 0.13x AU$32.23K AU$253.53K AU$16.12K ▲ +314.7%
2019 0.03x AU$91.20K AU$2.97 Million AU$91.20K ▲ +402.0%
2018 0.01x AU$2.54K AU$416.33K AU$2.54K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow